Impaired basal glucose effectiveness in NIDDS: Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol

Ananda Basu, Andrea Caumo, Francesca Bettini, Anna Gelisio, Aus Alzaid, Claudio Cobelli, Robert A. Rizza

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

People with NIDDM are resistant to insulin. The present studies sought to determine whether the ability of glucose to regulate its own metabolism in the presence of basal insulin concentrations is impaired. To address this question, basal insulin concentrations were maintained constant with an exogenous insulin infusion, while endogenous hormone secretion was inhibited by somatostatin. The integrated glycemic response above baseline during identical prandial glucose infusions was greater (1,411 ± 94 vs. 938 ± 45 mmol/l per 5 h; P <0.01) in the diabetic subjects than in the nondiabetic subjects, indicating a decrease in net glucose effectiveness. [6-3H]glucose also was infused to determine whether the decrease in net glucose effectiveness was due to a decrease in the ability of glucose to stimulate its own uptake and/or to suppress its own production. Despite identical rates of tracer infusion, the increment in plasma concentration of [6-3H]glucose was higher (4.50 ± 0.29 vs. 3.16 ± 0.21 x 105 dpm/ml per 5 h; P <0.05) in the diabetic subjects than in the nondiabetic subjects. This was due to both a decrease (P <0.05) in the ability of glucose to stimulate its own disappearance via mass action and to a greater (P <0.01) inhibitory effect of glucose on its own clearance. The increase in glucose concentration resulted in prompt and comparable suppression of endogenous glucose production in both groups. Under these optimized conditions, indexes of glucose effectiveness calculated with both the 'cold' and 'hot' minimal models also were lower (P <0.05) in the diabetic subjects than in the nondiabetic subjects and were highly correlated (r = 0.94-0.99; P <0.001) with the indexes of glucose effectiveness calculated from the increments above baseline of glucose and [63H]glucose concentration. We conclude that the ability of glucose to regulate its own metabolism in the presence of basal insulin concentrations is abnormal in people with NIDDM.

Original languageEnglish
Pages (from-to)421-432
Number of pages12
JournalDiabetes
Volume46
Issue number3
Publication statusPublished - Mar 1997

Fingerprint

Glucose
Insulin
Type 2 Diabetes Mellitus
Somatostatin
Meals
Hormones

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Impaired basal glucose effectiveness in NIDDS : Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. / Basu, Ananda; Caumo, Andrea; Bettini, Francesca; Gelisio, Anna; Alzaid, Aus; Cobelli, Claudio; Rizza, Robert A.

In: Diabetes, Vol. 46, No. 3, 03.1997, p. 421-432.

Research output: Contribution to journalArticle

Basu, Ananda ; Caumo, Andrea ; Bettini, Francesca ; Gelisio, Anna ; Alzaid, Aus ; Cobelli, Claudio ; Rizza, Robert A. / Impaired basal glucose effectiveness in NIDDS : Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. In: Diabetes. 1997 ; Vol. 46, No. 3. pp. 421-432.
@article{b7c730f55b424ed8910a3fe723689b28,
title = "Impaired basal glucose effectiveness in NIDDS: Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol",
abstract = "People with NIDDM are resistant to insulin. The present studies sought to determine whether the ability of glucose to regulate its own metabolism in the presence of basal insulin concentrations is impaired. To address this question, basal insulin concentrations were maintained constant with an exogenous insulin infusion, while endogenous hormone secretion was inhibited by somatostatin. The integrated glycemic response above baseline during identical prandial glucose infusions was greater (1,411 ± 94 vs. 938 ± 45 mmol/l per 5 h; P <0.01) in the diabetic subjects than in the nondiabetic subjects, indicating a decrease in net glucose effectiveness. [6-3H]glucose also was infused to determine whether the decrease in net glucose effectiveness was due to a decrease in the ability of glucose to stimulate its own uptake and/or to suppress its own production. Despite identical rates of tracer infusion, the increment in plasma concentration of [6-3H]glucose was higher (4.50 ± 0.29 vs. 3.16 ± 0.21 x 105 dpm/ml per 5 h; P <0.05) in the diabetic subjects than in the nondiabetic subjects. This was due to both a decrease (P <0.05) in the ability of glucose to stimulate its own disappearance via mass action and to a greater (P <0.01) inhibitory effect of glucose on its own clearance. The increase in glucose concentration resulted in prompt and comparable suppression of endogenous glucose production in both groups. Under these optimized conditions, indexes of glucose effectiveness calculated with both the 'cold' and 'hot' minimal models also were lower (P <0.05) in the diabetic subjects than in the nondiabetic subjects and were highly correlated (r = 0.94-0.99; P <0.001) with the indexes of glucose effectiveness calculated from the increments above baseline of glucose and [63H]glucose concentration. We conclude that the ability of glucose to regulate its own metabolism in the presence of basal insulin concentrations is abnormal in people with NIDDM.",
author = "Ananda Basu and Andrea Caumo and Francesca Bettini and Anna Gelisio and Aus Alzaid and Claudio Cobelli and Rizza, {Robert A.}",
year = "1997",
month = "3",
language = "English",
volume = "46",
pages = "421--432",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "3",

}

TY - JOUR

T1 - Impaired basal glucose effectiveness in NIDDS

T2 - Contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol

AU - Basu, Ananda

AU - Caumo, Andrea

AU - Bettini, Francesca

AU - Gelisio, Anna

AU - Alzaid, Aus

AU - Cobelli, Claudio

AU - Rizza, Robert A.

PY - 1997/3

Y1 - 1997/3

N2 - People with NIDDM are resistant to insulin. The present studies sought to determine whether the ability of glucose to regulate its own metabolism in the presence of basal insulin concentrations is impaired. To address this question, basal insulin concentrations were maintained constant with an exogenous insulin infusion, while endogenous hormone secretion was inhibited by somatostatin. The integrated glycemic response above baseline during identical prandial glucose infusions was greater (1,411 ± 94 vs. 938 ± 45 mmol/l per 5 h; P <0.01) in the diabetic subjects than in the nondiabetic subjects, indicating a decrease in net glucose effectiveness. [6-3H]glucose also was infused to determine whether the decrease in net glucose effectiveness was due to a decrease in the ability of glucose to stimulate its own uptake and/or to suppress its own production. Despite identical rates of tracer infusion, the increment in plasma concentration of [6-3H]glucose was higher (4.50 ± 0.29 vs. 3.16 ± 0.21 x 105 dpm/ml per 5 h; P <0.05) in the diabetic subjects than in the nondiabetic subjects. This was due to both a decrease (P <0.05) in the ability of glucose to stimulate its own disappearance via mass action and to a greater (P <0.01) inhibitory effect of glucose on its own clearance. The increase in glucose concentration resulted in prompt and comparable suppression of endogenous glucose production in both groups. Under these optimized conditions, indexes of glucose effectiveness calculated with both the 'cold' and 'hot' minimal models also were lower (P <0.05) in the diabetic subjects than in the nondiabetic subjects and were highly correlated (r = 0.94-0.99; P <0.001) with the indexes of glucose effectiveness calculated from the increments above baseline of glucose and [63H]glucose concentration. We conclude that the ability of glucose to regulate its own metabolism in the presence of basal insulin concentrations is abnormal in people with NIDDM.

AB - People with NIDDM are resistant to insulin. The present studies sought to determine whether the ability of glucose to regulate its own metabolism in the presence of basal insulin concentrations is impaired. To address this question, basal insulin concentrations were maintained constant with an exogenous insulin infusion, while endogenous hormone secretion was inhibited by somatostatin. The integrated glycemic response above baseline during identical prandial glucose infusions was greater (1,411 ± 94 vs. 938 ± 45 mmol/l per 5 h; P <0.01) in the diabetic subjects than in the nondiabetic subjects, indicating a decrease in net glucose effectiveness. [6-3H]glucose also was infused to determine whether the decrease in net glucose effectiveness was due to a decrease in the ability of glucose to stimulate its own uptake and/or to suppress its own production. Despite identical rates of tracer infusion, the increment in plasma concentration of [6-3H]glucose was higher (4.50 ± 0.29 vs. 3.16 ± 0.21 x 105 dpm/ml per 5 h; P <0.05) in the diabetic subjects than in the nondiabetic subjects. This was due to both a decrease (P <0.05) in the ability of glucose to stimulate its own disappearance via mass action and to a greater (P <0.01) inhibitory effect of glucose on its own clearance. The increase in glucose concentration resulted in prompt and comparable suppression of endogenous glucose production in both groups. Under these optimized conditions, indexes of glucose effectiveness calculated with both the 'cold' and 'hot' minimal models also were lower (P <0.05) in the diabetic subjects than in the nondiabetic subjects and were highly correlated (r = 0.94-0.99; P <0.001) with the indexes of glucose effectiveness calculated from the increments above baseline of glucose and [63H]glucose concentration. We conclude that the ability of glucose to regulate its own metabolism in the presence of basal insulin concentrations is abnormal in people with NIDDM.

UR - http://www.scopus.com/inward/record.url?scp=0031054198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031054198&partnerID=8YFLogxK

M3 - Article

C2 - 9032098

AN - SCOPUS:0031054198

VL - 46

SP - 421

EP - 432

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 3

ER -